Quaker Chemical Corporation (KWR)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$161.50+0.73%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · KWR
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $162 KWR trades at 21× p/e, in line with its 17× p/e peer median — but our blended $139 fair value sits below the price. We hold it with medium confidence: our number sits below the analyst range. Analysts target $172–$198. Note: our $139 fair value sits below the entire analyst range ($172–$198). Even valued only for durable growth at sustainable margins, it's worth about $195 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $181.00 | — | — | Analyst | high |
| dcf fcff | 12M | $17.98 | — | — | Hist. CAGR | high |
| graham number | 12M | $116.77 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $38.25 | 10.0 | 7.99 | TTM | high |
| Peer P/FCF |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$172.00 – $198.00 (median $181.00) · 4 analysts · as of 2026-08-25
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 6% over what the business is worth with no growth; closing that gap needs roughly 3.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $8.31/sh owner earnings.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $104.82 |
| 21.1 |
| 4.97 |
| TTM |
| high |
| Peer P/E | 12M | $131.04 | 17.4 | 7.55 | TTM | high |
| Peer P/S | 12M | $166.41 | 1.4 | 114.85 | TTM | high |
| PEG | 12M | $184.18 | 24.4 | 7.55 | TTM | high |
| residual income | 12M | $80.63 | — | — | TTM | high |
| Own P/E history | 12M | $162.62 | 21.5 | 7.55 | TTM | high |
| triangulated | 12M | $132.87 | 17.4 | 7.66 | Triangulated | high |
| Peer P/FCF | 3Y | $66.00 | 21.1 | 3.13 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $181.67 | 17.4 | 10.47 | Analyst | medium |
| Peer P/S | 3Y | $197.05 | 1.4 | 136.00 | Analyst | medium |
| PEG | 3Y | $255.35 | 24.4 | 10.47 | Analyst | medium |
| Own P/E history | 3Y | $225.47 | 21.5 | 10.47 | Analyst | medium |
| Peer P/FCF | 5Y | $48.48 | 21.1 | 2.30 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $202.80 | 17.4 | 11.68 | Analyst | high |
| Peer P/S | 5Y | $219.96 | 1.4 | 151.81 | Analyst | high |
| PEG | 5Y | $285.04 | 24.4 | 11.68 | Analyst | high |
| Own P/E history | 5Y | $251.68 | 21.5 | 11.68 | Analyst | high |